The mitogen-activated/extracellular signal-regulated kinase kinase 1/2 inhibitor U0126 induces glial fibrillary acidic protein expression and reduces the proliferation and migration of C6 glioma cells |
| |
| Authors: | Lind C R P Gray C W Pearson A G Cameron R E O'Carroll S J Narayan P J Lim J Dragunow M |
| |
| Affiliation: | Department of Pharmacology and Clinical Pharmacology, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland, New Zealand. |
| |
| Abstract: | The extracellular signal-regulated kinase (ERK) signaling pathway has been implicated in diverse cellular functions. ERK and its activating kinase, mitogen-activated/extracellular signal-regulated kinase kinase (MEK), are downstream of cell surface receptors known to be up-regulated in many malignant gliomas. We sought to investigate the role of ERK in glioma cell migration, proliferation and differentiation using the rat-derived C6 glioma cell line and the MEK inhibitor, U0126. Treatment of C6 cells with U0126 caused a significant concentration-dependent reduction in cell proliferation and migration and also induced expression of glial fibrillary acidic protein, a marker of astrocytic differentiation. These results suggest that the ERK pathway regulates glioma cell proliferation, migration and differentiation. |
| |
| Keywords: | glioma glioblastoma mitogen-activated protein kinase kinase mitogen-activated protein kinase kinase inhibitors U0126 glial fibrillary acidic protein |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ |
